Salicylate Measurement: Clinical Usefulness and Methodology
- 1 January 1987
- journal article
- research article
- Published by Taylor & Francis in CRC Critical Reviews in Clinical Laboratory Sciences
- Vol. 25 (2) , 137-159
- https://doi.org/10.3109/10408368709105880
Abstract
The salicylates are the most commonly used analgesic, antipyretic, and anti-inflammatory drugs. They are available in hundreds of preparations, many of which are over-the-counter medications. The easy access to large quantities of the drug and the widespread perception that the drug is harmless have contributed to salicylate intoxication becoming a serious and common problem, particularly among the pediatric and geriatric populations. Salicylate is still the major drug for the treatment of rheumatic diseases. The use of salicylate in high doses for the management of these patients requires close monitoring of serum salicylate levels because of the large interindividual variation in dose-serum level relationships and the narrowness of the therapeutic range. Thus, both for the management of patients intoxicated with salicylate and patients who are on high-dose salicylate therapy, the measurement of serum salicylate levels is an important clinical laboratory service. Recent research on the inhibitory effect of aspirin on platelet aggregation has led to the prophylactic use of aspirin in low doses as an antithrombotic drug. This new therapeutic use of aspirin can be aided by monitoring low serum levels of salicylate and perhaps aspirin itself. This article reviews the current state of the knowledge of the pharmacokinetics and clinical toxicology of salicylate, the clinical usefulness of salicylate measurement by the clinical laboratory, and recent development in the analytical technology for salicylate analysis.Keywords
This publication has 143 references indexed in Scilit:
- Public Health Service Study on Reye’s Syndrome and MedicationsNew England Journal of Medicine, 1985
- Dose-Related Kinetics of AspirinNew England Journal of Medicine, 1984
- Therapy of Ischemic Cerebral Vascular Disease Due to AtherothrombosisNew England Journal of Medicine, 1984
- Aspirin as an Antithrombotic MedicationNew England Journal of Medicine, 1983
- Differential Inhibition by Aspirin of Vascular and Platelet Prostaglandin Synthesis in Atherosclerotic PatientsNew England Journal of Medicine, 1983
- Importance of Protein Binding for the Interpretation of Serum or Plasma Drug ConcentrationsThe Journal of Clinical Pharmacology, 1982
- Arachidonic Acid Metabolites and the Interactions between Platelets and Blood-Vessel WallsNew England Journal of Medicine, 1979
- Aspirin and Thromboembolism — A Possible DilemmaNew England Journal of Medicine, 1977
- Inhibition of prostaglandin synthesis in manBiochemical and Biophysical Research Communications, 1972
- A simplified urine and serum screening test for salicylate intoxicationThe Journal of Pediatrics, 1963